Automatic Website Traffic RSS

Novel Treatment For Damaged Corneas: Cell Therapy

Following treatment, all participants achieved a corneal endothelial cell density of more than 500 cells per square millimeter, with ten eyes having a density exceeding 1000 cells per square ... read more

Development of new corneal cell line provides powerful tool

Telomerase Immortalization of Human Corneal Endothelial Cells Yields Functional Hexagonal Monolayers. PLoS ONE , 2012; 7 (12): e51427 DOI: 10.1371/journal.pone.0051427 Cite This Page : ... read more

Eyedrops Using Novel Compound Restore Corneal Cells - Medscape

NEW ORLEANS — Rho kinase inhibitor eyedrops stimulate the growth of corneal epithelium, according to a preliminary study in patients with Fuchs dystrophy. "Think outside the box," said Shigeru ... read more

Trefoil Therapeutics Begins First Clinical Trial of Regenerative Treatment for Patients with Corneal Endothelial Dystrophies - Business Wire

Secondary endpoints include measures of visual acuity, corneal edema, and other measures of corneal endothelial cell growth. An observational study preceded the trial, in which patients underwent ... read more

Price Vision Group Participating in Clinical Study of Investigational Growth Factor Treatment for Eye Disorder, Fuchs Endothelial Corneal Dystrophy - Business Wire

About TTHX1114 TTHX1114 is an engineered form of the naturally occurring molecule Fibroblast Growth Factor-1 (FGF-1), which stimulates cell proliferation and migration as well as protects cells ... read more

VIDEO: Corneal endothelial cell therapy achieves primary endpoint

KOLOA, Hawaii — In this Healio Video Perspective from Hawaiian Eye 2025, Greg Kunst, CEO of Aurion Biotech, discusses positive phase 1/2 data for the company’s cell therapy for corneal ... read more

Aurion Biotech begins phase 1/2 US clinical trial of cell therapy for corneal edema

Aurion Biotech announced that the first participant has been dosed in its phase 1/2 trial of AURN001, an investigational cell therapy for treatment of corneal edema secondary to corneal ... read more

Price Vision Group Participating in Clinical Study of Investigational Growth Factor Treatment for Eye Disorder, Fuchs Endothelial Corneal Dystrophy

FECD, the most common corneal endothelial disorder, is the leading cause of corneal transplantation/graft in the U.S. The hallmark of FECD is excessive loss of endothelial cells and the formation of ... read more